Table 1.
Demographic and intraoperative data
| Variable | Inhalation anesthetics (n = 31) |
Remimazolam (n = 33) |
P |
|---|---|---|---|
| Age, years | 46.0 [30.0; 53.5] | 45.0 [30.0; 53.0] | 0.925 |
| Weight (kg) | 70.5 ± 14.0 | 70.0 ± 12.0 | 0.891 |
| BMI (kg/m2) | 25.4 ± 4.1 | 24.8 ± 3.4 | 0.509 |
| ASA physical status (I/II) | 7/24 | 4/29 | 0.437 |
| Duration of anesthesia, min | 91.0 [77.5; 110.0] | 90.0 [75.0; 106.0] | 0.567 |
| Amount of intravenous fluid, mL | 300.0 [250.0; 500.0] | 400.0 [300.0; 500.0] | 0.114 |
| Amount of irrigation fluid, mL | 300.0 [200.0; 400.0] | 300.0 [125.0; 350.0] | 0.558 |
| Estimated blood loss, mL | 20.0 [10.5; 27.5] | 13.0 [10.0; 25.0] | 0.533 |
| Ambient temperature at the beginning of surgery, °C |
22.3 ± 1.0 | 22.1 ± 1.0 | 0.312 |
| Ambient temperature at the end of surgery, °C | 22.4 [22.0; 22.9] | 22.4 [21.7; 22.7] | 0.505 |
| Baseline body temperature, °C | 36.9 ± 0.4 | 36.9 ± 0.4 | 0.494 |
| Baseline SBP, mmHg | 141.839 ± 19.5 | 134.7 ± 14.2 | 0.099 |
| Baseline HR, rate/min | 77.1 ± 14.3 | 72.8 ± 12.1 | 0.200 |
| Use of hemodynamic drugs | |||
| Phenylephrine | 2 (6.5%) | 3 (9.0%) | 0.999 |
| Nicardipine | 7 (22.6%) | 4 (12.1%) | 0.437 |
| Ephedrine | 17 (54.8%) | 18 (54.5%) | 0.999 |
| Atropine | 1 (3.2%) | 0 (0%) | 0.975 |
| Esmolol | 9 (29.0%) | 3 (9.1%) | 0.085 |
Data are expressed as mean ± standard deviation, median (interquartile range), number, or number (%). ASA: American Society of Anesthesiologists